WKYT | Lexington, Kentucky | News

Two-day hearing to decide fate of diabetes pill

WASHINGTON (AP) - Hearings begin today on whether the drug Avandia should stay on the market.

Ahead of the hearings, FDA scientists have blasted a study by drug maker GlaxoSmithKline used to defend the safety of the once high-riding diabetes drug, which fell out of favor because of potential ties to heart attacks.

In fact, one FDA reviewer says the study actually makes the case against leaving Avandia on the market.

For the Food and Drug Administration, Avandia represents the latest in a series of drugs that were approved years ago, only to be called into question later because of safety concerns.

Regulators have three likely options: Add more warning labels; limit which doctors can prescribe Avandia; or, pull it from the market altogether.

Comments are posted from viewers like you and do not always reflect the views of this station.
powered by Disqus


2851 Winchester Rd. Lexington, Ky 40509 859-299-0411 - switchboard 859-299-2727 - newsroom
Register for Email
RSS Feeds
Copyright © 2002-2015 - Designed by Gray Digital Media - Powered by Clickability 98311699 - wkyt.com/a?a=98311699
Gray Television, Inc.